| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/1999 | EP0888121A1 Use of vasopressin receptor antagonist for regulation of acth release |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888110A1 Composite gel microparticles as active principle carriers |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0866683A4 Composition and method for treating diseased nails |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0719282B1 Aids and sle prophylactics |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0625195B1 Therapy of central nervous system by genetically modified cells |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0528841B1 A method for the preparation of pyridoxylated hemoglobin |
| 01/07/1999 | EP0525076B1 Recombinant bile salt activated lipases |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/07/1999 | DE19726823A1 Detoxifizierungsproteine Detoxifizierungsproteine |
| 01/07/1999 | CA2313015A1 Cyclosporin-containing microemulsion preconcentrate composition |
| 01/07/1999 | CA2297256A1 Method for improving the efficacy of a probiotic, preparation of food additives and animal feed containing same |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295326A1 Cardiotrophin-like cytokine |
| 01/07/1999 | CA2295319A1 New human cathepsin |
| 01/07/1999 | CA2295318A1 Human extracellular matrix proteins |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295229A1 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294904A1 Control of acidic gut syndrome |
| 01/07/1999 | CA2294725A1 Intra-oral antioxidant preparations |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | CA2292794A1 Ace-inhibitor nitric salts |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1204367A Antifungal proteins |
| 01/06/1999 | CN1204366A Antifungal protein |
| 01/06/1999 | CN1204342A Antineoplastic peptides |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/06/1999 | CN1204263A Method for effecting changes in central nervous system by administration of IGF-I or IGF-II |
| 01/06/1999 | CN1204262A Stable pharmaceutical forms of administration containing parathormone |
| 01/06/1999 | CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856477 Hypotensive agents; congestive heart failure |
| 01/05/1999 | US5856476 Processes for preparing azepiones useful as intermediates in the preparation of inhibitors of angiotensin converting enzyme and neutral endopeptidase |
| 01/05/1999 | US5856466 Coupling 2'-o-alkylated guanosine 3'-o-phosphoramidite with a 5'-hydroxyl moiety on an oligonucleotide |
| 01/05/1999 | US5856463 PSKH-1 ribozymes |
| 01/05/1999 | US5856462 Oligonucleotides having modified CpG dinucleosides |
| 01/05/1999 | US5856461 Antibody |
| 01/05/1999 | US5856457 To obtain dna encoding pf4a receptors, and to express them in host cells. |
| 01/05/1999 | US5856451 Conjugating a polypeptide with a polymer |
| 01/05/1999 | US5856449 Glycoprotein |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856446 Method of treating rheumatoid arthritis with low dose type II collagen |
| 01/05/1999 | US5856445 Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator |
| 01/05/1999 | US5856444 Physiologically active substance having activity in acting on the megakaryocyte-platelet system, in promoting differentiation,maturation, and/or proliferation therein, and in promoting the formation of platelets, and in promoting the |
| 01/05/1999 | US5856442 Relates to a procedure for obtaining immunomodulating soluble proteins. |
| 01/05/1999 | US5856441 Serrate fragments and derivatives |
| 01/05/1999 | US5856439 Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
| 01/05/1999 | US5856438 Its gram-negative bactericidal properties and its ability to bind to and neutralize lps, treatment of mammals suffering from diseases caused by gram-negative bacteria |
| 01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856363 Arthritis treatment |
| 01/05/1999 | US5856353 Sulfonamide inhibitors of aspartyl protease |
| 01/05/1999 | US5856321 Preparation of carbapenems |
| 01/05/1999 | US5856310 Inhibition of farnesyltransferase |
| 01/05/1999 | US5856309 Treating osteoporosis, inflammation or a disease which is due to a thromboembolic event |
| 01/05/1999 | US5856307 Peptide derivatives as kininogenase inhibitors |
| 01/05/1999 | US5856306 Oligopeptides modified with boron fragment |
| 01/05/1999 | US5856305 Inflammatory rheumatoid arthritis |
| 01/05/1999 | US5856303 Polypeptide |
| 01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 01/05/1999 | US5856301 Administering polypeptide |
| 01/05/1999 | US5856300 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| 01/05/1999 | US5856298 Increasing hematocrit levels in mammals comprising administering a therapeutically acceptable amount of these compositions to increase production of reticulocytes and red blood cells. |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856296 DNA encoding interleukin-4 receptors |
| 01/05/1999 | US5856201 Methods of detection using a cellulose binding domain fusion product |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856185 Method for making reflection defective retroviral vectors for infecting human cells |
| 01/05/1999 | US5856184 Isolated domains of type IV collagen to modify cell and tissue interactions |
| 01/05/1999 | US5856171 Cell death regulators |
| 01/05/1999 | US5856169 Isolated nucleic acid |
| 01/05/1999 | US5856161 Tumor necrosis factor receptor-I-associated protein kinase and methods for its use |
| 01/05/1999 | US5856160 Polynucleotides; hybrid detector |
| 01/05/1999 | US5856158 Used to degrad arginine to citrulline and nitric oxide |
| 01/05/1999 | US5856155 Nucleic acid which encodes a polypeptide consisting of a core region of a .beta.-subunit of a shaker-like potassium ion channel |
| 01/05/1999 | US5856153 Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases |
| 01/05/1999 | US5856152 Transgenic supplying to cells |
| 01/05/1999 | US5856151 Antifungal preparations containing osmotin |
| 01/05/1999 | US5856140 Human interleukin-2 response blocker |
| 01/05/1999 | US5856138 Human parathyroid hormone muteins and production thereof |
| 01/05/1999 | US5856137 Nucleic acids encoding and recombinant production of the β subunit of lutenizing hormone |
| 01/05/1999 | US5856136 Human stem cell antigens |
| 01/05/1999 | US5856134 Polypeptide antigens which are immunoreactive with sera from individuals having a non-a, non-b, non-c, non-d, non-e hepatitis. |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856131 Genetic engineered expression vectors and cells |